Here Mark will trade stocks and options in the Biotech/RX sector and follows two easily overlooked catalysts. The first one depends on a three-letter federal agency with the potential to attract investors like bees to honey. The second catalyst is less obvious, but just as powerful.
Author: Six Figure Catalyst Trader
In the end, there's really only one good reason to even consider joining Mark in his advisory service. It's his track record; a track record that makes traditional investments pale in comparison.
Mark says, “There's always a way to profit as long as investors buy stocks for stupid reasons” and his track record is proof of that: Over the last two and a half years, Mark’s track record has been no less than staggering. Find out if Mark’s strategies are right for you.